GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm
- PMID: 26257060
- DOI: 10.1038/onc.2015.294
GNAS(R201H) and Kras(G12D) cooperate to promote murine pancreatic tumorigenesis recapitulating human intraductal papillary mucinous neoplasm
Abstract
Intraductal papillary mucinous neoplasm (IPMN), the most common pancreatic cystic neoplasm, is known to progress to invasive ductal adenocarcinoma. IPMNs commonly harbor activating somatic mutations in GNAS and KRAS, primarily GNAS(R201H) and KRAS(G12D). GNAS encodes the stimulatory G-protein α subunit (Gsα) that mediates a stimulatory signal to adenylyl cyclase to produce cyclic adenosine monophosphate (cAMP), subsequently activating cAMP-dependent protein kinase A. The GNAS(R201H) mutation results in constitutive activation of Gsα. To study the potential role of GNAS in pancreatic tumorigenesis in vivo, we generated lines of transgenic mice in which the transgene consisted of Lox-STOP-Lox (LSL)-GNAS(R201H) under the control of the CAG promoter (Tg(CAG-LSL-GNAS)). These mice were crossed with pancreatic transcription factor 1a (Ptf1a)-Cre mice (Ptf1a(Cre/+)), generating Tg(CAG-LSL-GNAS);Ptf1a(Cre/+) mice. This mouse line showed elevated cAMP levels, small dilated tubular complex formation, loss of acinar cells and fibrosis in the pancreas; however, no macroscopic tumorigenesis was apparent by 2 months of age. We then crossed Tg(CAG-LSL-GNAS);Ptf1a(Cre/+) mice with LSL-Kras(G12D) mice, generating Tg(CAG-LSL-GNAS);LSL-Kras(G12D);Ptf1a(Cre/+) mice. We used these mice to investigate a possible cooperative effect of GNAS(R201H) and Kras(G12D) in pancreatic tumorigenesis. Within 5 weeks, Tg(CAG-LSL-GNAS);LSL-Kras(G12D);Ptf1a(Cre/+) mice developed a cystic tumor consisting of marked dilated ducts lined with papillary dysplastic epithelia in the pancreas, which closely mimicked the human IPMN. Our data strongly suggest that activating mutations in GNAS and Kras cooperatively promote murine pancreatic tumorigenesis, which recapitulates IPMN. Our mouse model may serve as a unique in vivo platform to find biomarkers and effective drugs for diseases associated with GNAS mutations.
Similar articles
-
Loss of Activin Receptor Type 1B Accelerates Development of Intraductal Papillary Mucinous Neoplasms in Mice With Activated KRAS.Gastroenterology. 2016 Jan;150(1):218-228.e12. doi: 10.1053/j.gastro.2015.09.013. Epub 2015 Sep 25. Gastroenterology. 2016. PMID: 26408346 Free PMC article.
-
Metabolic reprogramming by mutant GNAS creates an actionable dependency in intraductal papillary mucinous neoplasms of the pancreas.Gut. 2024 Dec 10;74(1):75-88. doi: 10.1136/gutjnl-2024-332412. Gut. 2024. PMID: 39277181 Free PMC article.
-
GNASR201C Induces Pancreatic Cystic Neoplasms in Mice That Express Activated KRAS by Inhibiting YAP1 Signaling.Gastroenterology. 2018 Nov;155(5):1593-1607.e12. doi: 10.1053/j.gastro.2018.08.006. Epub 2018 Aug 22. Gastroenterology. 2018. PMID: 30142336 Free PMC article.
-
Clinical assessment of the GNAS mutation status in patients with intraductal papillary mucinous neoplasm of the pancreas.Surg Today. 2019 Nov;49(11):887-893. doi: 10.1007/s00595-019-01797-7. Epub 2019 Mar 16. Surg Today. 2019. PMID: 30879148 Review.
-
Intraductal Papillary Mucinous Carcinoma Versus Conventional Pancreatic Ductal Adenocarcinoma: A Comprehensive Review of Clinical-Pathological Features, Outcomes, and Molecular Insights.Int J Mol Sci. 2021 Jun 23;22(13):6756. doi: 10.3390/ijms22136756. Int J Mol Sci. 2021. PMID: 34201897 Free PMC article. Review.
Cited by
-
Deficient Rnf43 potentiates hyperactive Kras-mediated pancreatic preneoplasia initiation and malignant transformation.Animal Model Exp Med. 2022 Feb;5(1):61-71. doi: 10.1002/ame2.12203. Epub 2022 Jan 22. Animal Model Exp Med. 2022. PMID: 35229994 Free PMC article.
-
A Pilot, Prospective, Observational Study to Investigate the Value of NGS in Liquid Biopsies to Predict Tumor Response After Neoadjuvant Chemo-Radiotherapy in Patients With Locally Advanced Rectal Cancer: The LiBReCa Study.Front Oncol. 2022 Jun 28;12:900945. doi: 10.3389/fonc.2022.900945. eCollection 2022. Front Oncol. 2022. PMID: 35837093 Free PMC article.
-
Fibroblasts in Pancreatic Ductal Adenocarcinoma: Biological Mechanisms and Therapeutic Targets.Gastroenterology. 2019 May;156(7):2085-2096. doi: 10.1053/j.gastro.2018.12.044. Epub 2019 Feb 2. Gastroenterology. 2019. PMID: 30721663 Free PMC article. Review.
-
Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database.Oncologist. 2025 Mar 10;30(3):oyaf007. doi: 10.1093/oncolo/oyaf007. Oncologist. 2025. PMID: 40079530 Free PMC article.
-
The GNAQ T96S Mutation Affects Cell Signaling and Enhances the Oncogenic Properties of Hepatocellular Carcinoma.Int J Mol Sci. 2021 Mar 23;22(6):3284. doi: 10.3390/ijms22063284. Int J Mol Sci. 2021. PMID: 33807071 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Miscellaneous